Guidance
Evidence-based recommendations on UroShield for preventing catheter-associated urinary tract infections.
Is this guidance up to date?
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.
Guidance development process
How we develop NICE medical technologies guidance
NICE medical technologies guidance addresses specific technologies notified to NICE by companies. The ‘case for adoption’ is based on the claimed advantages of introducing the specific technology compared with current management of the condition. This case is reviewed against the evidence submitted and expert advice.
This guidance updates and replaces NICE’s medtech innovation briefing on UroShield for preventing catheter-associated urinary tract infections (MIB191).